Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06653621

Effect of Bupivacaine Liposomes or Bupivacaine for Femoral Triangle or Adductor Block on Analgesia After Total Knee Replacement

Effect of Bupivacaine Liposomes or Bupivacaine for Femoral Triangle or Adductor Block on Analgesia After Total Knee Replacement: a Prospective, Single-center, Simple Randomized, Active-controlled, Single-blind, 2x2 Factorial Design Clinical Study

Status
Not Yet Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
144 (estimated)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to investigate the effect of bupivacaine liposomes on postoperative pain in TKA ( total knee replacement ) patients.The main questions answered are: 1. Is bupivacaine liposomes superior to bupivacaine in femoral triangle block or adductor block in terms of 72 hours opioid consumption after knee replacement 2. Which block method(Femoral triangle block or adductor block) combined with bupivacaine liposome was more effective in alleviating pain score and 72 hours opioid consumption after total knee surgery. investigators will investigate the effect of bupivacaine liposomes combined with bupivacaine and pure bupivacaine on pain after total knee arthroplasty using femoral triangle block or adductor block. Participants will: 1. Receive liposomal bupivacaine or bupivacaine as a regional anesthetic for femoral triangle block or adductor block under ultrasound guidance. 2. Undergo total knee replacement surgery under spinal anesthesia. 3. Follow-up within 72 hours after surgery , opioid consumption, NRS score, PCA(Patient controlled analgesia,PCA) data, first postoperative remedial analgesia time, quadriceps muscle strength and complications were recorded

Detailed description

The patients received femoral triangle block plus iPACK(infiltration between popliteal artery and capsule of knee) block or adductor canal block plus iPACK block during induction . The local anesthetic formulation was bupivacaine (0.75% bupivacaine hydrochloride 10ml+ normal saline 20ml) or bupivacaine liposome (0.75% bupivacaine hydrochloride 10ml+ bupivacaine liposome 20ml(266mg)).

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine liposomeSubjects receive liposomal bupivacaine as a regional anesthetic for femoral triangle block or adductor block under ultrasound guidance.
PROCEDURENerve block mode : adductor blockSubjects receive liposomal bupivacaine or bupivacaine as a regional anesthetic for adductor block under ultrasound guidance.
DRUGBupivacaineSubjects receive bupivacaine as a regional anesthetic for femoral triangle block or adductor block under ultrasound guidance.
PROCEDURENerve block mode: femoral triangle blockSubjects receive liposomal bupivacaine or bupivacaine as a regional anesthetic for femoral triangle block under ultrasound guidance.

Timeline

Start date
2024-11-05
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2024-10-22
Last updated
2024-10-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06653621. Inclusion in this directory is not an endorsement.